Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice.
about
Investigational drugs to treat methicillin-resistant Staphylococcus aureusStaphylococcal manipulation of host immune responsesWill there ever be a universal Staphylococcus aureus vaccine?Where does a Staphylococcus aureus vaccine stand?Progress toward a Staphylococcus aureus vaccineStaphylococcus aureus biofilms: properties, regulation, and roles in human diseaseDevelopment of a vaccine against Staphylococcus aureusContribution of coagulases towards Staphylococcus aureus disease and protective immunityA new and robust method of tethering IgG surrogate antigens on lipid bilayer membranes to facilitate the TIRFM based live cell and single molecule imaging experiments.The bicomponent pore-forming leucocidins of Staphylococcus aureusStaphylococcus aureus infection induces protein A-mediated immune evasion in humans.Host chemokines bind to Staphylococcus aureus and stimulate protein A release.Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infectionEvaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.EsaD, a secretion factor for the Ess pathway in Staphylococcus aureusRecombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.A play in four acts: Staphylococcus aureus abscess formationProtein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs.Igniting the fire: Staphylococcus aureus virulence factors in the pathogenesis of sepsis.Protein A is released into the Staphylococcus aureus culture supernatant with an unprocessed sorting signalIdentifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responsesVaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureusProtein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus.Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infectionSuppression of conformational heterogeneity at a protein-protein interface.Intramammary Immunization of Pregnant Mice with Staphylococcal Protein A Reduces the Post-Challenge Mammary Gland Bacterial Load but Not Pathology.Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses.Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection.Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice.Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureusInnate Immune Signaling Activated by MDR Bacteria in the AirwayRecurrent infections and immune evasion strategies of Staphylococcus aureus.Exploring Staphylococcus aureus pathways to disease for vaccine development.Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.Immunopathogenesis of Staphylococcus aureus pulmonary infection.Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesisIn vivo VL-targeted microbial superantigen induced global shifts in the B cell repertoire.Importance of B Lymphocytes and the IgG-Binding Protein Sbi in Staphylococcus aureus Skin Infection.Peptidoglycan-linked protein A promotes T cell-dependent antibody expansion during Staphylococcus aureus infectionStaphylococcal Protein A Promotes Colonization and Immune Evasion of the Epidemic Healthcare-Associated MRSA ST239
P2860
Q26780246-4139586D-F43D-4BDF-B6BC-4C10F629903BQ26798461-5F2C5E30-491F-42F5-9B7A-8A243D6938F2Q26824837-2B8080C6-934E-485C-B851-5F156A57D52EQ26828726-5AE41ACB-0C2D-49AB-BB02-BFDBC707B07EQ26829702-50145474-8C8E-46A9-BBAB-34AD6F44FA9BQ27006715-8B684841-A017-4F4C-A80B-11A7697CE022Q27015365-BF53B828-CBAB-48A7-8135-FC22576E3D18Q27313924-9915530D-3FAE-4C02-885F-A9674E1B7631Q30454349-A676E03C-1064-429E-99B9-E3643D97265DQ33743499-1CE37DC3-1F9E-4ACE-8C83-ECA535AA048FQ34533083-07E25932-DAFC-40EB-9977-A73A1DE27E4DQ34568302-3D04FC87-B941-476C-AB43-E50D3C4971D2Q34596203-912FFF0B-326C-4399-A4DE-149411FB79E2Q34712265-314F4482-97AB-4B62-BEE2-FD96B3B9587BQ34740873-6257827A-7CC4-40E2-A158-36CDFF9AEB31Q34889865-F62B1625-242E-4280-9BA2-6E6B026E2D3EQ34928131-E01D04D0-90C4-4AA2-B463-9D3B3706AA47Q35038206-32468024-39A5-453A-AAD2-F8F89B97E833Q35097096-085E954B-A68D-44F9-889A-DACE914FE040Q35187633-5BDB75BE-733A-4969-B3FF-938AF448207EQ35225082-0BF14A67-2CF4-486C-9A8C-0C67611DE1EAQ35229369-F2116994-6C5A-469F-ADCA-C070D0FC7BDBQ35229922-95CF6E60-EFEC-44A6-9413-4B4A682D44E0Q35880774-CD17546F-C266-4125-9AD0-7F372FBE2D0DQ35895521-7273B72D-2A95-451D-9ED5-F8EC4C027F4CQ35919380-E0B34E31-3546-479A-A593-F9BC733ECFEBQ35976060-A979F945-3A70-4041-8560-80C705C932ADQ36277405-7504DBA5-4F08-4433-84B0-0CD257114CF3Q36277427-83288E6C-DB1D-42DD-AAD0-998742772022Q36380959-D980FEC5-A4D7-46EC-8AF8-C87069D6E1E1Q36422470-527C171F-33E8-4EEB-8271-B0AE86773BD9Q36513761-AA7737EE-B04F-4B10-AF6D-490798766095Q36516970-058C722E-8A8F-4B80-9127-9D81B22692D7Q36548288-E95B4981-0F53-4343-9812-972F00E9B41DQ36623309-8F99F284-05E5-4FA8-A321-F5D7105E946FQ36636170-2630B9B4-7718-44F4-A29C-A8C93CD90CC3Q36687539-6C4B6968-BA1A-4902-974B-9EF5100280C3Q36735408-C4EC047B-089E-4F5A-976F-790CBF3F56EBQ36930930-269C941B-33FD-4F7A-B508-3AC204A5F67FQ37040623-80CDBC12-7668-4DA0-ACC4-A86379A3710C
P2860
Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nontoxigenic protein A vaccine ...... cus aureus infections in mice.
@ast
Nontoxigenic protein A vaccine ...... cus aureus infections in mice.
@en
Nontoxigenic protein A vaccine ...... cus aureus infections in mice.
@nl
type
label
Nontoxigenic protein A vaccine ...... cus aureus infections in mice.
@ast
Nontoxigenic protein A vaccine ...... cus aureus infections in mice.
@en
Nontoxigenic protein A vaccine ...... cus aureus infections in mice.
@nl
prefLabel
Nontoxigenic protein A vaccine ...... cus aureus infections in mice.
@ast
Nontoxigenic protein A vaccine ...... cus aureus infections in mice.
@en
Nontoxigenic protein A vaccine ...... cus aureus infections in mice.
@nl
P2093
P2860
P356
P1476
Nontoxigenic protein A vaccine ...... cus aureus infections in mice.
@en
P2093
Alice G Cheng
Dominique M Missiakas
Hwan Keun Kim
Hye-Young Kim
P2860
P304
P356
10.1084/JEM.20092514
P407
P577
2010-08-16T00:00:00Z